Common Shares, Without Par Value
- Symbol
- ABT
- Exchange
- NYSE
- Classification
- COMMON
- Status
- Current
Current Report · Items 8.01, 9.01 · 8-K
Abbott Laboratories
ABTNYSEEQUITYCurrent
Other Events
Item 8.01 Other Events. Filed as Exhibit 99.1, and incorporated herein by reference, is the news release issued by Abbott announcing that it plans to separate its global nutrition business into an independent, publicly traded company.
Company context
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 122,000 colleagues serve people in more than 160 countries. Connect with us at www.abbott.com and on LinkedIn, Facebook, Instagram, X, and YouTube.
Current securities
Registered securities in this filing
ABBOTT LABORATORIES · 8-K · Filed 2026-10-21
Common Shares, Without Par Value
- Symbol
- ABT
- Exchange
- NYSE
- Classification
- COMMON
- Status
- Current
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events.
Filed as Exhibit 99.1, and
incorporated herein by reference, is the news release issued by Abbott announcing that it plans to separate its global nutrition business
into an independent, publicly traded company.
Filed exhibits (1)
Exhibit 99.1 Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded company Separation will unlock potential of both companies to pursue distinct growth and value-creation strategies The new Nutrition company will be a global leader in the rapidly growing healthy nutrition market, with a portfolio of iconic, category-leading brands, including Similac, PediaSure, Pedialyte, Glucerna and Ensure Abbott will have accelerated sales growth and an expanded margin profile Abbott intends to separate its Nutrition business through a tax-free distribution to Abbott shareholders Separation expected to be completed by the end of 2027 ABBOTT PARK, Ill., Oct. 21, 2026 - Abbott, the global healthcare leader, today announced its intention to separate its Nutrition business into an independent publicly traded company that will be a global leader in the rapidly expanding healthy nutrition market with approximately $8.5 billion in annual sales and a portfolio of iconic brands. “As we continue to shape Abbott for the future, this separation will benefit both companies, setting each one up for maximum success in its …
Open exhibit ↗